Moderate riskFDA DrugClass II

International Medication Systems epinephrine injection recalled for sterility concerns

International Medication Systems Ltd. is recalling one lot of epinephrine injection due to concerns that the sterility of the product cannot be assured. The affected lot (EA038A5, expiring 08/2026) was distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using epinephrine injection lot EA038A5 immediately
  2. Contact your pharmacy or healthcare provider if you have this lot
  3. Do not use this medication; contact FDA or the manufacturer for instructions on safe disposal

Is yours affected?

Compare your label or packaging with the recalled product.

Product
EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
81,520 units
Illnesses reported
None reported
Manufactured in
1886 Santa Anita Ave, N/A, South El Monte, CA, United States
Classification
Class II
Recall number
D-0483-2026

In the FDA's words

Description
EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA 91733, An Amphastar Pharmaceutical Company, NDC 76329-3318-1 Lack of Assurance of Sterility Lot Number: EA038A5, Expiration Date: 08/2026. Distribution: U.S. Nationwide Affected quantity: 81,520 units
Hazard
Lack of Assurance of Sterility

Related topics

SterilityDrugsSold nationwideMore from FDA Drug